Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) Short Interest Down 44.7% in June

Virtus LifeSci Biotech Products ETF (NYSEARCA:BBP) saw a large drop in short interest in June. As of June 15th, there was short interest totaling 7,733 shares, a drop of 44.7% from the May 31st total of 13,976 shares. Based on an average trading volume of 5,224 shares, the days-to-cover ratio is currently 1.5 days. Approximately 1.1% of the shares of the stock are short sold.

Virtus LifeSci Biotech Products ETF Price Performance

BBP traded down $0.25 on Wednesday, reaching $96.02. The stock had a trading volume of 9,937 shares, compared to its average volume of 7,818. Virtus LifeSci Biotech Products ETF has a fifty-two week low of $58.52 and a fifty-two week high of $97.49. The firm has a 50-day moving average of $87.69 and a 200-day moving average of $84.19.

Institutional Trading of Virtus LifeSci Biotech Products ETF

Hedge funds and other institutional investors have recently made changes to their positions in the company. Comprehensive Financial Planning Inc. PA bought a new position in Virtus LifeSci Biotech Products ETF in the 4th quarter valued at approximately $557,000. Flow Traders U.S. LLC acquired a new stake in Virtus LifeSci Biotech Products ETF during the 2nd quarter worth approximately $431,000. Finally, Prime Capital Investment Advisors LLC bought a new stake in Virtus LifeSci Biotech Products ETF during the 4th quarter worth approximately $1,896,000.

About Virtus LifeSci Biotech Products ETF

The Virtus LifeSci Biotech Products ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is managed by Virtus.